All In Biotech

Drug Trial Radar · NCT00789581

A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

Phase III Study of Doxorubicin/Cyclophosphamide (AC) Followed by Ixabepilone vs. AC Followed by Paclitaxel in Patients With Triple-Negative Early-Stage Breast Cancer

Last checked: Nov 20, 2026Latest source record: Jul 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 614 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

614

Actual

Start

Dec 2008

Primary completion

Dec 2015

Study completion Nov 2016

Sponsor

Lead sponsor
SCRI Development Innovations, LLCAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bristol-Myers Squibb
First posted
Nov 13, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, Phase III, open-label, multicenter study.

Conditions

  • Breast Cancer

Interventions

  • DoxorubicinDrug

    Doxorubicin 60 mg/m2

  • CyclophosphamideDrug

    Cyclophosphamide 600 mg/m2

  • Ixabepilone (Ixempra)Drug

    Ixabepilone 40 mg/m2

  • Paclitaxel (Taxol)Drug

    Paclitaxel 80 mg/m2

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free SurvivalTime frame: up to 5.25 years (63 months)

Locations

70 sites in 2 countries. Site status is shown where the registry gives one.

  • Northeast Alabama Regional Medical Center

    Anniston, Alabama

  • Cancer Center of Huntsville

    Huntsville, Alabama

  • Clearview Cancer Institute

    Huntsville, Alabama

  • University of Southern Alabama

    Mobile, Alabama

  • Northeast Arkansas Clinic

    Jonesboro, Arkansas

  • Wilshire Oncology Medical Group

    La Verne, California

  • New Hope Cancer and Research Institute

    Pomona, California

  • Eastern Connecticut Hematology Oncology

    Norwich, Connecticut

  • Aventura Medical Center

    Aventura, Florida

  • Lynn Cancer Institute

    Boca Raton, Florida

  • Florida Cancer Care

    Davie, Florida

  • Holy Cross Hospital

    Fort Lauderdale, Florida

  • Florida Cancer Specialists

    Fort Myers, Florida

  • Memorial Regional Cancer Center

    Hollywood, Florida

  • Integrated Community Oncology Network

    Jacksonville, Florida

  • Watson Clinic Center for Cancer Care and Research

    Lakeland, Florida

  • Space Coast Medical Associates

    Titusville, Florida

  • Piedmont Healthcare

    Atlanta, Georgia

  • Emory/Winship Cancer Institute

    Atlanta, Georgia

  • Augusta Oncology Associates

    Augusta, Georgia

  • Medical Oncology Associates of Augusta

    Augusta, Georgia

  • Medical College of Georgia Cancer Specialists

    Augusta, Georgia

  • Northeast Georgia Medical Center

    Gainesville, Georgia

  • Suburban Hem Onc

    Lawrenceville, Georgia

  • Mid-Illinois Hematology & Oncology

    Normal, Illinois

  • Hematology Oncology of the North Shore

    Skokie, Illinois

  • Oncology Hematology Associates of SW Indiana

    Evansville, Indiana

  • Hematology Oncology of Indiana

    Indianapolis, Indiana

  • Providence Medical Group

    Terre Haute, Indiana

  • Kansas City Cancer Centers

    Overland Park, Kansas

  • Cotton O'Neil Cancer Center

    Topeka, Kansas

  • Consultants in Blood Disorders and Cancer

    Louisville, Kentucky

  • Baton Rouge General Medical Center

    Baton Rouge, Louisiana

  • Mercy Hospital

    Portland, Maine

  • Weinberg Cancer Institute at Franklin Square

    Baltimore, Maryland

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland

  • Fallon Clinic

    Worcester, Massachusetts

  • Grand Rapids Clinical Oncology Program

    Grand Rapids, Michigan

  • Fairview Medical Oncology Clinic

    Edina, Minnesota

  • St. Louis Cancer Care

    Chesterfield, Missouri

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.